Gene · 2938
Papers2,060
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,060
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantitative proteomic analysis shows involvement of the p38 MAPK pathway in bovine parainfluenza virus type 3 replication. | Virol J | 2022 | 35831876 | PubTator, text mining | PubMed |
| Systems biology models to identify the influence of SARS-CoV-2 infections to the progression of human autoimmune diseases. | Inform Med Unlocked | 2022 | 35818398 | PubTator, text mining | PubMed |
| Combinatory Exposure to Urolithin A, Alternariol, and Deoxynivalenol Affects Colon Cancer Metabolism and Epithelial Barrier Integrity in vitro. | Front Nutr | 2022 | 35811943 | PubTator, text mining | PubMed |
| COL5A1 Promotes the Progression of Gastric Cancer by Acting as a ceRNA of miR-137-3p to Upregulate FSTL1 Expression. | Cancers (Basel) | 2022 | 35805015 | PubTator, text mining | PubMed |
| RNA-sequencing reveals genes linked with oocyte developmental potential in bovine cumulus cells. | Mol Reprod Dev | 2022 | 35802551 | PubTator, text mining | PubMed |
| The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review. | Pharmgenomics Pers Med | 2022 | 35795337 | PubTator, text mining | PubMed |
| Pharmaceutical and nutraceutical potential of natural bioactive pigment: astaxanthin. | Nat Prod Bioprospect | 2022 | 35794254 | PubTator, text mining | PubMed |
| Influence of Glutathione-S-Transferase A1*B Allele on the Metabolism of the Aromatase Inhibitor, Exemestane, in Human Liver Cytosols and in Patients Treated With Exemestane. | J Pharmacol Exp Ther | 2022 | 35793834 | PubTator, text mining | PubMed |
| The Correlation Between Busulfan Exposure and Clinical Outcomes in Chinese Pediatric Patients: A Population Pharmacokinetic Study. | Front Pharmacol | 2022 | 35784763 | PubTator, text mining | PubMed |
| "Commandeuring" Xenobiotic Metabolism: Advances in Understanding Xenobiotic Metabolism. | Chem Res Toxicol | 2022 | 35768066 | PubTator, text mining | PubMed |
| Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery. | Eur Neuropsychopharmacol | 2022 | 35763977 | PubTator, text mining | PubMed |
| Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation. | Pharmaceutics | 2022 | 35745718 | PubTator, text mining | PubMed |
| Chitosan and Chitooligosaccharide: The Promising Non-Plant-Derived Prebiotics with Multiple Biological Activities. | Int J Mol Sci | 2022 | 35743209 | PubTator, text mining | PubMed |
| Exposure to the Dioxin-like Pollutant PCB 126 Afflicts Coronary Endothelial Cells via Increasing 4-Hydroxy-2 Nonenal: A Role for Aldehyde Dehydrogenase 2. | Toxics | 2022 | 35736936 | PubTator, text mining | PubMed |
| Establishment of Repeated In Vitro Exposure System for Evaluating Pulmonary Toxicity of Representative Criteria Air Pollutants Using Advanced Bronchial Mucosa Models. | Toxics | 2022 | 35736886 | PubTator, text mining | PubMed |
| Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways. | Clin Mol Hepatol | 2022 | 35730208 | PubTator, text mining | PubMed |
| Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature. | Hepatol Commun | 2022 | 35712812 | PubTator, text mining | PubMed |
| Pharmacogenomics of Clozapine-induced agranulocytosis: a systematic review and meta-analysis. | Pharmacogenomics J | 2022 | 35710824 | PubTator, text mining | PubMed |
| Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancer. | Sci Rep | 2022 | 35710704 | PubTator, text mining | PubMed |
| Exploratory Investigation of the Plasma Proteome Associated with the Endotheliopathy of Trauma. | Int J Mol Sci | 2022 | 35682894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2938/papers?page=17